ArticleViruses2022

Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern.

Mahali S Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.